JP2023540123A5 - - Google Patents
Info
- Publication number
- JP2023540123A5 JP2023540123A5 JP2023515071A JP2023515071A JP2023540123A5 JP 2023540123 A5 JP2023540123 A5 JP 2023540123A5 JP 2023515071 A JP2023515071 A JP 2023515071A JP 2023515071 A JP2023515071 A JP 2023515071A JP 2023540123 A5 JP2023540123 A5 JP 2023540123A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- polypeptide chain
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074747P | 2020-09-04 | 2020-09-04 | |
| US63/074,747 | 2020-09-04 | ||
| PCT/US2021/048786 WO2022051449A2 (en) | 2020-09-04 | 2021-09-02 | T cell receptors recognizing r273c or y220c mutations in p53 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540123A JP2023540123A (ja) | 2023-09-21 |
| JP2023540123A5 true JP2023540123A5 (enExample) | 2024-09-06 |
Family
ID=77924530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515071A Pending JP2023540123A (ja) | 2020-09-04 | 2021-09-02 | Ｐ５３におけるｒ２７３ｃ又はｙ２２０ｃの変異を認識するｔ細胞受容体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230321240A1 (enExample) |
| EP (1) | EP4208473A2 (enExample) |
| JP (1) | JP2023540123A (enExample) |
| KR (1) | KR20230066023A (enExample) |
| CN (1) | CN116472050A (enExample) |
| AU (1) | AU2021336399A1 (enExample) |
| CA (1) | CA3191186A1 (enExample) |
| GB (1) | GB2614166A (enExample) |
| TW (1) | TWI900647B (enExample) |
| WO (1) | WO2022051449A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024206274A2 (en) | 2023-03-27 | 2024-10-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors targeting y220c or r175h mutation in p53 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| MX375379B (es) | 2014-05-29 | 2025-03-06 | Us Health | Receptores de celulas t anti - papilomavirus 16 e7 humano. |
| WO2018102585A1 (en) * | 2016-11-30 | 2018-06-07 | Advaxis, Inc. | Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations |
| US20210147550A1 (en) * | 2017-08-18 | 2021-05-20 | Joshua Michael Francis | Antigen-binding proteins targeting shared antigens |
| SG11202002635RA (en) * | 2017-09-29 | 2020-04-29 | The United States Of America As Represented By The Secretary | Methods of isolating t cells having antigenic specificity for a p53 cancer-specific mutation |
| WO2019067243A1 (en) * | 2017-09-29 | 2019-04-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T CELL RECEPTORS RECOGNIZING P53 MUTE |
-
2021
- 2021-09-02 TW TW110132552A patent/TWI900647B/zh active
- 2021-09-02 KR KR1020237011380A patent/KR20230066023A/ko active Pending
- 2021-09-02 US US18/024,557 patent/US20230321240A1/en active Pending
- 2021-09-02 AU AU2021336399A patent/AU2021336399A1/en active Pending
- 2021-09-02 EP EP21778318.2A patent/EP4208473A2/en active Pending
- 2021-09-02 WO PCT/US2021/048786 patent/WO2022051449A2/en not_active Ceased
- 2021-09-02 CN CN202180071809.1A patent/CN116472050A/zh active Pending
- 2021-09-02 JP JP2023515071A patent/JP2023540123A/ja active Pending
- 2021-09-02 CA CA3191186A patent/CA3191186A1/en active Pending
- 2021-09-02 GB GB2304187.4A patent/GB2614166A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022538148A5 (enExample) | ||
| KR20230079259A (ko) | Kras 돌연변이 특이적 t세포 수용체의 스크리닝 및 항종양 용도 | |
| Ljunggren et al. | Empty MHC class I molecules come out in the cold | |
| JP2021505136A5 (enExample) | ||
| JP2024517884A5 (enExample) | ||
| CN112110995A (zh) | 肿瘤新抗原多肽及其用途 | |
| JP2020534828A5 (enExample) | ||
| Carbone et al. | T cell receptor α-chain pairing determines the specificity of residue 262 within the Kb-restricted, ovalbumin257–264 determinant | |
| JPH08109199A (ja) | Ｔ細胞抗原受容体に対する抗体 | |
| GB2609760A (en) | HLA Class I-restricted T cell receptors against RAS with G12D mutation | |
| JP2022523024A5 (enExample) | ||
| JP2024502235A5 (enExample) | ||
| JP2023527613A (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| CN113621048A (zh) | T细胞抗原受体、其多聚体复合物及其制备方法和应用 | |
| JP2023534241A5 (enExample) | ||
| CN114302962A (zh) | 特异性针对来源于ebv抗原的tcr构建体 | |
| WO2006058496A1 (fr) | Épitope d'antigène mimétique de her-2 et composition qui comprend un tel épitope | |
| JP5189094B2 (ja) | 無差別ｐａｐｃｄ４ｔ細胞エピトープ | |
| CN120607607A (zh) | 针对含有g12r突变的ras的hla第ii类限制性t细胞受体 | |
| JP2023540123A5 (enExample) | ||
| CN111378039A (zh) | 治疗恶性肿瘤的抗体及其应用 | |
| JP2023535366A5 (enExample) | ||
| GB2614166A (en) | T cell receptors recognizing R273C or Y220C mutations in P53 | |
| US8658177B2 (en) | Promiscuous HER-2/Neu CD4 T cell epitopes | |
| US20210382070A1 (en) | Diagnostic biomarkers for shrimp allergy |